<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Friedman AJ</submitter><funding>University of Colorado Boulder</funding><funding>Think Bioscience</funding><funding>National Institute of General Medical Sciences</funding><funding>Colorado State University</funding><funding>Division of Chemical, Bioengineering, Environmental, and Transport Systems</funding><funding>NIGMS NIH HHS</funding><pagination>8305-8316</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10694825</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>127(39)</volume><pubmed_abstract>Protein tyrosine phosphatases (PTPs) are emerging drug targets for many diseases, including cancer, autoimmunity, and neurological disorders. A high degree of structural similarity between their catalytic domains, however, has hindered the development of selective pharmacological agents. Our previous research uncovered two unfunctionalized terpenoid inhibitors that selectively inhibit PTP1B over T-cell PTP (TCPTP), two PTPs with high sequence conservation. Here, we use molecular modeling, with supporting experimental validation, to study the molecular basis of this unusual selectivity. Molecular dynamics (MD) simulations suggest that PTP1B and TCPTP share a h-bond network that connects the active site to a distal allosteric pocket; this network stabilizes the closed conformation of the cat</pubmed_abstract><journal>The journal of physical chemistry. B</journal><pubmed_title>Biophysical Rationale for the Selective Inhibition of PTP1B over TCPTP by Nonpolar Terpenoids.</pubmed_title><pmcid>PMC10694825</pmcid><funding_grant_id>R35GM143089</funding_grant_id><funding_grant_id>CBET 1750244</funding_grant_id><funding_grant_id>R35 GM143089</funding_grant_id><pubmed_authors>Shirts MR</pubmed_authors><pubmed_authors>Donovan GW</pubmed_authors><pubmed_authors>Fox JM</pubmed_authors><pubmed_authors>Friedman AJ</pubmed_authors><pubmed_authors>Kramer L</pubmed_authors><pubmed_authors>Padgette HM</pubmed_authors><pubmed_authors>Liechty ET</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biophysical Rationale for the Selective Inhibition of PTP1B over TCPTP by Nonpolar Terpenoids.</name><description>Protein tyrosine phosphatases (PTPs) are emerging drug targets for many diseases, including cancer, autoimmunity, and neurological disorders. A high degree of structural similarity between their catalytic domains, however, has hindered the development of selective pharmacological agents. Our previous research uncovered two unfunctionalized terpenoid inhibitors that selectively inhibit PTP1B over T-cell PTP (TCPTP), two PTPs with high sequence conservation. Here, we use molecular modeling, with supporting experimental validation, to study the molecular basis of this unusual selectivity. Molecular dynamics (MD) simulations suggest that PTP1B and TCPTP share a h-bond network that connects the active site to a distal allosteric pocket; this network stabilizes the closed conformation of the cat</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-05-28T09:01:01.602Z</modification><creation>2025-02-19T04:25:07.021Z</creation></dates><accession>S-EPMC10694825</accession><cross_references><pubmed>37729547</pubmed><doi>10.1021/acs.jpcb.3c03791</doi></cross_references></HashMap>